<DOC>
	<DOCNO>NCT00145262</DOCNO>
	<brief_summary>Clinical study establish implantation bone marrow mononuclear cell ( BM-MNCs ) peripheral blood mononuclear cell ( PB-MNCs ) ischaemic limbs increase collateral vessel formation . We , investigator Nagoya University , investigate efficacy safety autologous implantation BM-MNCs PB-MNCs patient severe ischaemic limb alternative therapeutic option . We also examine potential limiting factor reduce efficacy therapeutic angiogenesis use cell transplantation ( TACT ) .</brief_summary>
	<brief_title>TACT-NAGOYA : Therapeutic Angiogenesis Using Cell Transplantation</brief_title>
	<detailed_description />
	<mesh_term>Arteriosclerosis</mesh_term>
	<mesh_term>Thromboangiitis Obliterans</mesh_term>
	<mesh_term>Arteriosclerosis Obliterans</mesh_term>
	<criteria>Subjects chronic limb ischemia , include rest pain , nonhealing ischemic ulcer , , candidate nonsurgical surgical revascularisation . Poorly control diabetes mellitus ( hemoglobin A1c [ HbA1c ] &gt; 6.5 % proliferative retinopathy ) Evidence malignant disorder past 5 year Subjects survive 1 year complication Malignant rheumatic arthritis</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2003</verification_date>
	<keyword>critical limb ischemia</keyword>
	<keyword>bone marrow mononuclear cell</keyword>
	<keyword>angiogenesis</keyword>
	<keyword>vasculogenesis</keyword>
	<keyword>Arteriosclerosis Obliterans ( ASO )</keyword>
	<keyword>Ischemic ulcer</keyword>
</DOC>